Andy Pike

Andy Pike is a Senior DMPK lead at AstraZeneca, where they focus on discovery and development. Previously, they served as a research project leader and DMPK lead at Pfizer from 2008 to 2016, managing the delivery of development candidates in pain and neuroscience therapeutic areas. Prior to that, from 1993 to 2006, they worked as a bioanalyst and DMPK scientist at Merck, providing vital pharmacokinetic and ADME data. Andy also led the discovery DMPK group at Astex Therapeutics from 2006 to 2008, and briefly worked as a consultant at Neuro-Bio Limited in 2016.